Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | F2 | P00734 | 1/20 | 0.57 |
| ▸ | PRSS1 | P07477 | 1/20 | 0.57 |
| ▸ | PRSS2 | P07478 | 1/20 | 0.57 |
| ▸ | PRSS3 | P35030 | 1/20 | 0.57 |
| ▸ | TMPRSS6 | Q8IU80 | 1/20 | 0.57 |
| ▸ | ST14 | Q9Y5Y6 | 1/20 | 0.57 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.53 |
| ▸ | MEN1 | O00255 | 2/20 | 0.52 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.52 |
| ▸ | MITF | O75030 | 1/20 | 0.52 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.50 |
| ▸ | TP53 | P04637 | 1/20 | 0.50 |
| ▸ | TSHR | P16473 | 1/20 | 0.50 |
| ▸ | CA1 | P00915 | 1/20 | 0.49 |
| ▸ | CA2 | P00918 | 1/20 | 0.49 |
| ▸ | PTPN11 | Q06124 | 1/20 | 0.49 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.49 |
| ▸ | NR1H4 | Q96RI1 | 1/20 | 0.49 |
| ▸ | POLB | P06746 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| 4-Guanidino-Benzoic Acid SCHEMBL10674543 | 0.98 | F2 (0.55) | F2PRSS1PRSS2PRSS3TMPRSS6 | |
| 4-Guanidino-Benzoic Acid SCHEMBL22127093 | 0.98 | F2 (0.55) | F2PRSS1PRSS2PRSS3TMPRSS6 | |
| 4-Guanidino-Benzoic Acid SCHEMBL11123754 | 0.98 | F2 (0.55) | F2PRSS1PRSS2PRSS3TMPRSS6 | |
| 4-Guanidino-Benzoic Acid SCHEMBL273175 | 0.98 | F2 (0.55) | F2PRSS1PRSS2PRSS3TMPRSS6 | |
| 4-Guanidino-Benzoic Acid SCHEMBL28796971 | 0.96 | F2 (0.53) | F2PRSS1PRSS2PRSS3TMPRSS6 | |
| 4-Guanidino-Benzoic Acid SCHEMBL22127091 | 0.96 | F2 (0.58) | F2PRSS1PRSS2PRSS3TMPRSS6 | |
| 4-Guanidino-Benzoic Acid SCHEMBL7563601 | 0.91 | CA2 (0.50) | F2PRSS1PRSS2PRSS3TMPRSS6 | |
| 4-Guanidino-Benzoic Acid SCHEMBL19205978 | 0.91 | CA2 (0.50) | F2PRSS1PRSS2PRSS3TMPRSS6 | |
| 4-Guanidino-Benzoic Acid SCHEMBL9303333 | 0.89 | F2 (0.61) | F2PRSS1PRSS2PRSS3TMPRSS6 | |
| SCHEMBL11569991 | 0.85 | KMT2A (0.54) | F2PRSS1PRSS2PRSS3TMPRSS6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1002 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-121586379-A | Preparation method of high-quality perovskite thick film for X-ray detector | 中国矿业大学 | 2026-02-27 | — | — | CN | claimed |
| US-12408548-B2 | Perovskite layer, fabrication method and use the same | CITY UNIVERSITY OF HONG KONG (HK) | 2025-09-02 | — | — | US | claimed |
| CN-119947554-A | Perovskite layer, manufacturing method thereof and solar cell | 香港城市大学 | 2025-05-06 | — | — | CN | claimed |
| US-20250143173-A1 | PEROVSKITE LAYER, FABRICATION METHOD AND USE THE SAME | CITY UNIVERSITY OF HONG KONG (HK) | 2025-05-01 | — | — | US | claimed |
| CN-119390614-A | Preparation method of nafamostat mesylate | 河北广祥制药有限公司 | 2025-02-07 | — | — | CN | claimed |
| CN-119143635-A | Method for preparing nafamostat mesylate | 北京诺康达医药科技股份有限公司 | 2024-12-17 | — | — | CN | claimed |
| CN-119143634-A | Preparation method of nafamostat mesylate | 北京诺康达医药科技股份有限公司 | 2024-12-17 | — | — | CN | claimed |
| US-20240226128-A1 | NOVEL COMPOUNDS WITH DUAL INHIBITION ACTIVITY AGAINST SARS-COV-2 CRITICAL ENZYMES RDRP, MPRO AND HUMAN TMPRSS2 | UNIVERSITY OF SHARJAH (AE) | 2024-07-11 | — | — | US | claimed |
| CN-117986161-A | Synthesis method of high-purity anti-hemagglutination medicament | 华仁医学研究(安徽)有限公司 | 2024-05-07 | — | — | CN | claimed |
| CN-117986571-A | Hyperbranched poly (beta-amino ester) with different groups at tail ends, and preparation method and application thereof | 西安交通大学 | 2024-05-07 | — | — | CN | claimed |
| EP-0222608-A2 | Derivatives of p-guanidinobenzoic acid and pharmaceutical agents containing them as active ingredient | ONO PHARMACEUTICAL CO., LTD. (JP) | 1987-05-20 | — | — | EP | claimed |
| EP-0214429-A1 | Benzoyl esters | KOWA CO. LTD. (JP) | 1987-03-18 | — | — | EP | claimed |
| EP-0048433-B1 | NOVEL AMIDINE COMPOUNDS, PROCESS FOR PRODUCING SAME AND ANTI-COMPLEMENT AGENT COMPRISING THEM | TORII & CO., LTD. (JP) | 1986-05-28 | — | — | EP | claimed |
| EP-0170180-A1 | Substituted guanidinobenzoic-acid phenyl esters, process for their production and their use as pharmaceutical preparations | SCHERING AKTIENGESELLSCHAFT (DE) | 1986-02-05 | — | — | EP | claimed |
| EP-0024780-B1 | MEDICATED INTRAUTERINE DEVICES | Shaw, Seth Thomas, Jr. (US) | 1984-10-17 | — | — | EP | claimed |
| EP-0024779-B1 | DRUGS FOR USE WITH INTRAUTERINE DEVICES AND INTRAUTERINE DEVICES CONTAINING SAID DRUGS | Shaw, Seth Thomas, Jr. (US) | 1984-10-17 | — | — | EP | claimed |
| EP-0024781-B1 | MEDICATED INTRAUTERINE DEVICES | Shaw, Seth Thomas, Jr. (US) | 1984-08-08 | — | — | EP | claimed |
| EP-0009879-B1 | ENZYME DERIVATIVES FOR USE IN THE TREATMENT OF VENOUS THROMBOSIS, COMPOSITIONS CONTAINING THEM AND THEIR PREPARATION | BEECHAM GROUP PLC (GB) | 1983-10-12 | — | — | EP | claimed |
| EP-0028489-B1 | ENZYME DERIVATIVES, AND THEIR PREPARATION | BEECHAM GROUP PLC (GB) | 1983-10-05 | — | — | EP | claimed |
| US-4258030-A | ENZYME INHIBITOR AS STABILIZER | ZERIA-SHINYAKU KOGYO KABUSHIKI KAISHA (JP) | 1981-03-24 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250143173-A1 | PEROVSKITE LAYER, FABRICATION METHOD AND USE THE SAME | KCNQ1, KCNQ2, SCNN1B | F2 4794/4885PRSS1 2304/4885PRSS2 2422/4885 |
| US-12408548-B2 | Perovskite layer, fabrication method and use the same | KCNQ1, KCNQ2, SCNN1B | F2 4794/4885PRSS1 2304/4885PRSS2 2422/4885 |
| US-20240226128-A1 | NOVEL COMPOUNDS WITH DUAL INHIBITION ACTIVITY AGAINST SARS-COV-2 CRITICAL ENZYMES RDRP, MPRO AND HUMAN TMPRSS2 | TMPRSS2, ACE2, TMPRSS4 | F2 2611/4885PRSS1 10/4885PRSS2 4/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.